Microdialysis for pharmacokinetic analysis of drug transport to the brain

Advanced Drug Delivery Reviews

Volumn 36, Issue 2-3, 1999, Pages 211-227

  De Lange, Elizabeth C M ^a   De Boer, Bert A G ^a   Breimer, Douwe D ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Blood brain barrier; Brain extracellular fluid; Microdialysis

Indexed keywords

BLOOD; BRAIN; DIALYSIS; NEUROPHYSIOLOGY; PHARMACOKINETICS; PROTEINS; SURGERY;

BLOOD-BRAIN BARRIER; BRAIN EXTRACELLULAR FLUID; MICRODIALYSIS;

CONTROLLED DRUG DELIVERY;

ATENOLOL; ETOPOSIDE; FLUORESCEIN; GLYCOPROTEIN P; METHOTREXATE; PARACETAMOL; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; CEREBROSPINAL FLUID; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TRANSPORT; EXTRACELLULAR FLUID; MATHEMATICAL MODEL; MICRODIALYSIS; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

EID: 0033526157     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00089-1     Document Type: Review

References (72)

1. Bungay P.M., Morrison P.F., Dedrick R.L. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 46:1990;105-119.
2. Morrison P.F., Bungay P.M., Hsiao J.K., Ball B.A., Mefford I.N., Dedrick R.L. Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain. J. Neurochem. 57:1991;103-119.
3. P. Lonnröth, P.A. Jansson, U. Smith, A microdialysis method allowing characterization of intercellular water space in humans, Am. J. Physiol. Endocrinol. Metab. 253 (1987) E228-E231.
4. Olson R.J., Justice J.B. Quantitative microdialysis under transient conditions. Anal. Chem. 65:1993;1017-1023.
5. Oldendorf W.H. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res. 24:1970;372-376.
6. Kakke A., Terasaki T., Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J. Pharmacol. Exp. Ther. 277:1996;1550-1559.
7. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247:1984;H484-H493.
8. Matsushita H., Suzuki H., Suguyama Y., Sawada Y., Ida T., Kawaguchi T., Hanano H. Effects of benzylpenicillin on the disposition of cefodizine in rats: no net effect on total clearance due to increased hepatobiliary clearance and increased renal clearance. J. Pharmacol. Exp. Ther. 260:1992;499-504.
9. Aird R.B. A study of intrathecal, cerebrospinal fluid-to-brain exchange. Exp. Neurol. 86:1984;342-358.
10. Danhof M., Levy G. Kinetics of drug action in disease states. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex. J. Pharmacol. Exp. Ther. 229:1984;44-50.
11. Covell D.G., Narang P.K., Poplack D.G. Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am. J. Physiol. 248:1985;R147-R156.
12. Stamford J.A. In vivo voltammetry: some methodological considerations. J. Neurosci. Methods. 17:1986;1-29.
13. Pantano P., Kuhr W.G. Enzyme modified microelectrode with millisecond response time. Curr. Sep. 10:1991;81.
14. 3H-MK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat. J. Neurosurg. 76:1992;127-133.
15. 14C-methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: A quantitative autoradiographic study. Cancer Res. 48 (1988) 694-701.
16. 19F nuclear magnetic resonance spectroscopy of neuroleptics: The first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain. Biol. Psychiatry. 30:1991;656-662.
17. 11C-labelled drugs in the dog, in: C. Beckers (Ed.), Positron Emission Tomography in Clinical Research and Clinical Diagnosis: Tracer Modelling and Radioreceptors. 1989, pp. 1087-1117.
18. Webb S., Ott R.J., Cherry S.R. Quantitation of blood-brain barrier permeability by positron emission tomography. Phys. Med. Biol. 34:1989;1767-1771.
19. Yu D.-W., Gatley S.J., Wolf A.P.et al. Synthesis of carbon-11 labeled ionidated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. J. Med. Chem. 35:1992;2178-2183.
20. U. Ungerstedt, Measurement of neurotransmitter release by intracranial dialysis, in: C.A. Marsden (Ed.), Measurement of Neurotransmitter Release in Vivo. Wiley and Sons, New York, 1984.
21. Benveniste H., Huttemeier P.C. Microdialysis - Theory and Application. Prog. Neurobiol. 35:1990;195-215.
22. Hammarlund-Udenaes M., Paalzow L.N., De Lange E.C.M. Drug equilibration across the blood-brain-barrier - pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14:1997;128-134.
23. Tellez S., Forges N., Roussin A., Hernandez L. Coupling of microdialysis with capillary electrophoresis: a new approach to the study of drug transfer between two compartments of the body in freely moving rats. J. Chromatogr. 64:1992;806-810.
24. K. Mock, M. Hail, Mylchreest, et al. Rapid high-sensitive mapping by liquid chromatography-mass spectrometry. J. Chromatogr. 646 (1993) 169-174.
25. Lunte S.M., O'Shea T.J. Pharmaceutical and biomedical application of capillary electrophoresis/electrochemistry. Electrophoresis. 15:1994;79-86.
26. Scheller D., Koib J. The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentrations from dialysate samples. J. Neurosci. Methods. 40:1991;31-38.
27. Wang Y., Wong S.L., Sawchuk R.J. Comparison of in vitro and in vivo calibration of microdialysis probes using retrodialysis. Curr. Sep. 10:1991;87.
28. Yokel R.A., Allen D.D. Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis. J. Pharm. Methods. 27:1992;135-142.
29. Wong S.L., Van Belle K., Sawchuk R.J. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid and cerebrospinal fluid-blood barriers in the rabbit: investigation on the inhibitory effect of probenecid utilizing microdialysis. J. Pharmacol. Exp. Ther. 265:1993;R1205-R1211.
30. Benveniste H., Drejer J., Schoesboe A., Diemer N.H. Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J. Neurochem. 49:1987;729-734.
31. Westerink B.H.C., De Vries J.B. Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J. Neurosci. 51:1988;683-687.
32. Allen D., Crooks P.A., Yokel R.A. 4-Trimethylantipyrine: a quaternary ammonium nonradionucleide marker for BBB integrity during in vivo microdialysis. J. Pharm. Methods. 28:1992;129-135.
33. De Lange E.C.M., Danhof M., De Boer A.G., Breimer D.D. Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain. Brain Res. 666:1994;1-8.
34. Westergren I., Nystrom B., Hamberger A., Johansson B.B. Intracerebral microdialysis and the blood-brain barrier. J. Neurochem. 64:1995;229-234.
35. de Lange E.C.M., Danhof M., de Boer A.G., Breimer D.D. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on blood-brain barrier transport of drugs. Brain Res. Rev. 25:1997;27-49.
36. 51-EDTA by microdialysis following probe injury. Acta Neurochir. S51:1990;46-48.
37. Oldendorf W.H. Lipid solubility and drug penetration of the blood-brain barrier. Proc. Exp. Biol. Med. 14:1974;813-816.
38. Rapoport S.I., Ohno K., Pettigrew K.D. Drug entry into the brain. Brain. Res. 172:1979;354-359.
39. Levin V.A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23:1980;682-684.
40. De Lange E.C.M., Zurcher C., Danhof M., De Boer A.G., Breimer D.D. Repeated microdialysis perfusions periprobe tissue reactions and BBB permeability. Brain Res. 702:1995;261-265.
41. De Lange E.C.M., Bouw M.R., Danhof M., De Boer A.G., Breimer D.D. Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain. Br. J. Pharmacol. 116:1995;2538-2544.
42. Rapoport S.I., Hori M., Klatzo I. Testing of a hypothesis for opening the blood-brain barrier. Am. J. Physiol. 223:1972;323-331.
43. Rapoport S.I., Robinson P.J. Tight junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann. NY Acad. Sci. 36:1985;251-267.
44. Neuwelt E.A., Barnett P.A., McCormick C.I., Frenkel E.P., Minna J.D. Osmotic blood-brain barrier modification: monocloncal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurg. 17:1985;419-423.
45. 14C-methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: A quantitative autoradiographic study. Cancer Res. 48:1985;694-701.
46. De Lange E.C.M., Hesselink M.B., Danhof M., De Boer A.G., Breimer D.D. The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics. Pharm. Res. 12:1995;129-133.
47. Fenstermacher J.D., Patlak C.S., Blasberg R.G. Transport of material between brain extracellular fluid, brain cells and blood. Fed. Proc. 33:1974;2070-2074.
48. J.D. Fenstermacher, D.P. Rall, C.S. Patlak, V.A. Levin, Ventricular perfusion as a technique for analysis of brain capillary permeability and extracellular transport. in: C. Crone, N. Lassen (Eds.), Capillary Permeability. Copenhagen, Munkgard, 1970, pp. 483-490.
49. Sendelbeck S.L., Urquhart J. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion. Brain Res. 328:1985;251-258.
50. Groothuis D.R., Molnar P., Blasberg R.G. Regional blood flow and blood-to-tissue transport in five brain tumor models. Prog. Exp. Tumor Res. 27:1984;132-153.
51. Hasegawa H., Ushio Y., Hayakawa T., Yamada K., Mogami H. Changes of the blood-brain barrier in experimental metastatic brain tumors. J. Neurosurg. 59:1983;304-310.
52. Shapiro W.R. Chemotherapy, animal models blood-brain barrier and pharmacology. Prog. Exp. Tumor Res. 29:1985;116-121.
53. De Lange E.C.M., De Vries J.D., Zurcher C., Danhof M., De Boer A.G., Breimer D.D. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm. Res. 12:1995;1924-1931.
54. Kartner N., Riordan J.R., Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cells. Science. 221:1983;1285-1288.
55. Gros P., Ben-Neriah Y., Croop J., Housman D.E. Isolation and overexpression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
56. Hsu S.I.-H., Lothstein L., Horwtz S.B. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J. Biol. Chem. 246:1989;12053-12062.
57. Devault A., Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10:1990;1652-1663.
58. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at the blood-brain barrier. Proc. Natl. Acad. Sci. USA. 86:1987;695-698.
59. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Immunohistochemical localization in normal tissue of different epitopes in multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37:1989;159-164.
60. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistant gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:1987;7735-7738.
61. Sugawara I., Hirofumi H., Tsuruo T., Mori S. Specialized localization of P-glycoprotein recognized by MRK-16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. 81:1990;727-730.
62. Grieg N.H., Soncrant T.T., Shetty H.U., Momma S., Smith Q., Rapoport S.I. Brain uptake and anticancer activities of vinctristine and vinblastine are restricted by the low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother. Pharmacol. 26:1990;263-268.
63. Lee J.-S., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the national cancer institute drug screen. Mol. Pharmacol. 46:1994;627-638.
64. Schinkel A.H., Smit J.J.M., Van Tellingen O., Beijnen J.H., Wagenaar E., Van Deemter L., Mol C.A.A.M., Van der Valk M.A., Robanus-Maandag E.C., Te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
65. Schinkel A.H., Wagenaar E., Van Deemter L., Mol C.A.A.M., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxine, and cyclosporin. A.J. Clin Invest. 96:1995;1698-1705.
66. E.C.M. De Lange, G. DeBock, A.H. Schinkel, A.G. DeBoer, D.D. Breimer, BBB transport of rhodamine-123 in mdr1a(-/-) and wild-type mice. Total brain versus microdialysis concentration profiles. 1997, Submitted.
67. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267:1992;24248-24252.
68. Lum B.L., Fisher G.A., Brophy N.A., Yahanda A.M., Adler K.M., Kaubisch S., Halsey J., Sikic B.I. Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer. 72:1993;3502-3514.
69. Tirelli U., D'Incalci M., Canetta R.et al. Etoposide (VP16-213) in malignant brain tumors: A phase II study. J. Clin. Oncol. 2:1984;432-437.
70. Colombo T., Broggini M., Torti L., Erba E., D'Incalci M. Pharmacokinetics of VP16-213 in lewis ung carcinoma bearing mice. Cancer Chemother. Pharmacol. 7:1982;127-131.
71. Unger C., Eibel H., Von Heyden H.-W., Krish B., Nagel G.A. Blut-hirnschranke und penetration von Zytostatika. Klin. Wochenschr. 63:1985;565-571.
72. E.C.M. De Lange, D.J. Van den Berg, A.G. De Boer, D.D. Breimer, Increase in BBB transport of etoposide in mdr1a(-/-) compared with wild-type mice; a study using intracerebral microdialysis. 1998, In preparation.